Operating Income Summary of Humana Inc.

Humana Inc.'s latest annual operating income in 2023 was 4.01 Billion USD , up 0.34% from previous year.
Humana Inc.'s latest quarterly operating income in 2024 Q1 was 1.14 Billion USD , up 344.99% from previous quarter.
Humana Inc. reported an annual operating income of 3.8 Billion USD in 2022, up 1.47% from previous year.
Humana Inc. reported an annual operating income of 3.74 Billion USD in 2021, down -24.45% from previous year.
Humana Inc. reported a quarterly operating income of 1.14 Billion USD for 2024 Q1, up 344.99% from previous quarter.
Humana Inc. reported a quarterly operating income of 1.2 Billion USD for 2024 Q2, up 5.22% from previous quarter.

Annual Operating Income Chart of Humana Inc. (2023 - 1990)

Historical Annual Operating Income of Humana Inc. (2023 - 1990)

Year	Operating Income	Operating Income Growth
2023	4.01 Billion USD	0.34%
2022	3.8 Billion USD	1.47%
2021	3.74 Billion USD	-24.45%
2020	4.95 Billion USD	33.54%
2019	3.71 Billion USD	61.95%
2018	2.29 Billion USD	-46.22%
2017	4.26 Billion USD	144.8%
2016	1.74 Billion USD	-33.47%
2015	2.61 Billion USD	10.8%
2014	2.36 Billion USD	14.6%
2013	2.06 Billion USD	2.23%
2012	2.01 Billion USD	-9.8%
2011	2.23 Billion USD	27.75%
2010	1.74 Billion USD	9.23%
2009	1.6 Billion USD	61.33%
2008	992.84 Million USD	-22.99%
2007	1.28 Billion USD	69.18%
2006	762.08 Million USD	80.71%
2005	421.71 Million USD	1.41%
2004	415.85 Million USD	20.64%
2003	344.71 Million USD	64.2%
2002	209.93 Million USD	14.67%
2001	183.08 Million USD	60.6%
2000	114 Million USD	128.22%
1999	-404 Million USD	-299.01%
1998	203 Million USD	-24.81%
1997	270 Million USD	1400.0%
1996	18 Million USD	-93.75%
1995	288 Million USD	12.06%
1994	257 Million USD	-90.53%
1993	2.71 Billion USD	-19.27%
1992	3.36 Billion USD	-36.38%
1991	5.28 Billion USD	23.41%
1990	4.28 Billion USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q3	728 Million USD	-39.78%
2024 Q1	1.14 Billion USD	344.99%
2024 Q2	1.2 Billion USD	5.22%
2023 FY	3.81 Billion USD	0.34%
2023 Q4	-469 Million USD	-139.08%
2023 Q3	1.2 Billion USD	-12.54%
2023 Q2	1.37 Billion USD	-19.77%
2023 Q1	1.71 Billion USD	1279.03%
2022 Q2	1.21 Billion USD	-5.74%
2022 Q3	1.17 Billion USD	-3.54%
2022 FY	3.8 Billion USD	1.47%
2022 Q1	1.28 Billion USD	4674.07%
2022 Q4	124 Million USD	-89.42%
2021 Q3	1.73 Billion USD	104.59%
2021 FY	3.74 Billion USD	-24.45%
2021 Q2	850 Million USD	-24.71%
2021 Q1	1.12 Billion USD	397.11%
2021 Q4	27 Million USD	-98.45%
2020 Q2	2.68 Billion USD	242.29%
2020 Q3	1.86 Billion USD	-30.59%
2020 Q4	-380 Million USD	-120.38%
2020 FY	4.95 Billion USD	33.54%
2020 Q1	785 Million USD	20.96%
2019 Q4	649 Million USD	-31.76%
2019 Q3	951 Million USD	-26.9%
2019 Q2	1.3 Billion USD	60.42%
2019 Q1	811 Million USD	63.18%
2019 FY	3.71 Billion USD	61.95%
2018 Q1	760 Million USD	34.28%
2018 FY	2.29 Billion USD	-46.22%
2018 Q2	72 Million USD	-90.53%
2018 Q3	963 Million USD	1237.5%
2018 Q4	497 Million USD	-48.39%
2017 Q2	1.1 Billion USD	-36.71%
2017 FY	4.26 Billion USD	144.8%
2017 Q4	566 Million USD	-34.03%
2017 Q3	858 Million USD	-22.0%
2017 Q1	1.73 Billion USD	496.8%
2016 Q4	-438 Million USD	-146.15%
2016 Q2	683 Million USD	24.86%
2016 FY	1.74 Billion USD	-33.47%
2016 Q1	547 Million USD	87.33%
2016 Q3	949 Million USD	38.95%
2015 Q4	292 Million USD	-57.99%
2015 Q2	840 Million USD	6.33%
2015 Q3	695 Million USD	-17.26%
2015 FY	2.61 Billion USD	10.8%
2015 Q1	790 Million USD	112.94%
2014 Q3	589 Million USD	-13.51%
2014 FY	2.36 Billion USD	14.6%
2014 Q4	371 Million USD	-37.01%
2014 Q2	681 Million USD	-5.55%
2014 Q1	721 Million USD	5250.0%
2013 Q4	-14 Million USD	-102.25%
2013 FY	2.06 Billion USD	2.23%
2013 Q3	621 Million USD	-9.87%
2013 Q2	689 Million USD	-9.93%
2013 Q1	765 Million USD	147.57%
2012 FY	2.01 Billion USD	-9.8%
2012 Q4	309 Million USD	-54.22%
2012 Q3	675 Million USD	19.68%
2012 Q2	564 Million USD	44.62%
2012 Q1	390 Million USD	24.61%
2011 FY	2.23 Billion USD	27.75%
2011 Q4	312.98 Million USD	-55.2%
2011 Q3	698.64 Million USD	-3.79%
2011 Q2	726.13 Million USD	46.19%
2011 Q1	496.71 Million USD	184.67%
2010 Q1	477.18 Million USD	19.68%
2010 Q2	599.33 Million USD	25.6%
2010 FY	1.74 Billion USD	9.23%
2010 Q3	696.12 Million USD	16.15%
2010 Q4	174.49 Million USD	-74.93%
2009 Q2	439.95 Million USD	49.76%
2009 Q3	469.34 Million USD	6.68%
2009 Q4	398.7 Million USD	-15.05%
2009 FY	1.6 Billion USD	61.33%
2009 Q1	293.76 Million USD	12.53%
2008 Q3	282.86 Million USD	-12.97%
2008 Q4	261.04 Million USD	-7.71%
2008 Q1	123.92 Million USD	-65.48%
2008 FY	992.84 Million USD	-22.99%
2008 Q2	325.01 Million USD	162.26%
2007 Q3	478.5 Million USD	40.91%
2007 Q2	339.59 Million USD	202.61%
2007 Q4	358.98 Million USD	-24.98%
2007 Q1	112.22 Million USD	-53.47%
2007 FY	1.28 Billion USD	69.18%
2006 FY	762.08 Million USD	80.71%
2006 Q4	241.18 Million USD	-3.29%
2006 Q3	249.37 Million USD	77.72%
2006 Q2	140.32 Million USD	6.95%
2006 Q1	131.2 Million USD	32.24%
2005 Q2	124.84 Million USD	7.0%
2005 Q3	66.67 Million USD	-46.59%
2005 Q4	99.21 Million USD	48.8%
2005 FY	421.71 Million USD	1.41%
2005 Q1	116.68 Million USD	84.47%
2004 FY	415.85 Million USD	20.64%
2004 Q3	127.47 Million USD	4.18%
2004 Q4	63.25 Million USD	-50.38%
2004 Q1	102.77 Million USD	3.07%
2004 Q2	122.35 Million USD	19.05%
2003 Q4	99.71 Million USD	6.74%
2003 Q2	104.19 Million USD	119.8%
2003 Q3	93.41 Million USD	-10.34%
2003 FY	344.71 Million USD	64.2%
2003 Q1	47.4 Million USD	1990.79%
2002 Q2	66.7 Million USD	-3.02%
2002 Q4	-2.5 Million USD	-103.26%
2002 FY	209.93 Million USD	14.67%
2002 Q1	68.77 Million USD	24.87%
2002 Q3	76.95 Million USD	15.37%
2001 Q4	55.08 Million USD	17.19%
2001 FY	183.08 Million USD	60.6%
2001 Q1	2.06 Billion USD	5983.97%
2001 Q2	2.1 Billion USD	1.86%
2001 Q3	47 Million USD	-97.77%
2000 Q3	2.22 Billion USD	9179.17%
2000 Q4	34 Million USD	-98.47%
2000 Q1	2.28 Billion USD	132.93%
2000 FY	114 Million USD	128.22%
2000 Q2	24 Million USD	-98.95%
1999 FY	-404 Million USD	-299.01%
1999 Q4	-6.92 Billion USD	-413.11%
1999 Q2	2.16 Billion USD	1.21%
1999 Q1	2.14 Billion USD	135.47%
1999 Q3	2.21 Billion USD	2.03%
1998 Q3	2.06 Billion USD	-2.09%
1998 Q4	-6.03 Billion USD	-392.3%
1998 Q2	2.11 Billion USD	2.13%
1998 Q1	2.06 Billion USD	145.36%
1998 FY	203 Million USD	-24.81%
1997 Q2	1.57 Billion USD	0.51%
1997 Q1	1.56 Billion USD	137.44%
1997 FY	270 Million USD	1400.0%
1997 Q4	-4.55 Billion USD	-370.01%
1997 Q3	1.68 Billion USD	7.25%
1996 Q4	-4.18 Billion USD	-373.2%
1996 Q3	1.53 Billion USD	18.51%
1996 Q1	1.37 Billion USD	154.36%
1996 Q2	1.29 Billion USD	-6.25%
1996 FY	18 Million USD	-93.75%
1995 Q4	-2.53 Billion USD	-362.76%
1995 FY	288 Million USD	12.06%
1995 Q2	940 Million USD	2.51%
1995 Q1	917 Million USD	144.17%
1995 Q3	964 Million USD	2.55%
1994 Q3	811 Million USD	7.42%
1994 Q2	755 Million USD	-1.05%
1994 Q1	763 Million USD	11.39%
1994 FY	257 Million USD	-90.53%
1994 Q4	-2.07 Billion USD	-355.98%
1993 FY	2.71 Billion USD	-19.27%
1993 Q2	673 Million USD	-0.88%
1993 Q3	678 Million USD	0.74%
1993 Q4	685 Million USD	1.03%
1993 Q1	679 Million USD	-19.55%
1992 FY	3.36 Billion USD	-36.38%
1992 Q2	1.47 Billion USD	0.2%
1992 Q3	-998 Million USD	-167.66%
1992 Q1	1.47 Billion USD	4.1%
1992 Q4	844 Million USD	184.57%
1991 Q1	88.8 Million USD	-92.56%
1991 FY	5.28 Billion USD	23.41%
1991 Q4	1.41 Billion USD	1495.94%
1991 Q2	88.8 Million USD	0.0%
1991 Q3	88.6 Million USD	-0.23%
1990 Q2	1.12 Billion USD	6.9%
1990 Q4	1.19 Billion USD	6.1%
1990 FY	4.28 Billion USD	0.0%
1990 Q1	1.05 Billion USD	0.0%
1990 Q3	1.12 Billion USD	-0.04%

Peer Operating Income Comparison of Humana Inc.

Name	Operating Income	Operating Income Difference
Cigna Corporation	8.53 Billion USD	52.987%
Centene Corporation	2.93 Billion USD	-36.962%
CVS Health Corporation	13.74 Billion USD	70.8%
Elevance Health Inc.	133.96 Billion USD	97.004%
Molina Healthcare, Inc.	1.57 Billion USD	-155.118%
Oscar Health, Inc.	-235.61 Million USD	1803.202%
UnitedHealth Group Incorporated	32.35 Billion USD	87.598%

Global Stocks Search

Humana Inc. (HUM)

Operating Income Summary of Humana Inc.

Annual Operating Income Chart of Humana Inc. (2023 - 1990)

Historical Annual Operating Income of Humana Inc. (2023 - 1990)

Peer Operating Income Comparison of Humana Inc.